Cases & Deals

  • Home
  • Practices
  • Funds managed by Invesco Asset Management Limited invest in Mereo BioPharma Group

Share

Funds managed by Invesco Asset Management Limited invest in Mereo BioPharma Group

July 2015

Client(s) Invesco Asset Management Limited

Jones Day advised Invesco Asset Management managed funds on their investment alongside Woodford Investment Management in the $119 million (c. £76.5 million) capital raise by Mereo BioPharma Group Ltd. Novartis Pharmaceuticals, through shares issued in consideration for the acquisition of clinical-stage development programs, will also hold an equity stake in Mereo.

Mereo is a recently-formed specialty biopharmaceutical company focused on developing innovative medicines, particularly in rare and specialist disease areas, through the acquisition of validated, mid-stage development programs from large biopharmaceutical or biotechnology companies.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.